174 related articles for article (PubMed ID: 32703544)
41. Parotid and parapharyngeal tumours: tissue characterization with dynamic magnetic resonance imaging.
Tsushima Y; Matsumoto M; Endo K
Br J Radiol; 1994 Apr; 67(796):342-5. PubMed ID: 8173873
[TBL] [Abstract][Full Text] [Related]
42. Is ultrasound alone sufficient for imaging superficial lobe benign parotid tumours before surgery?
Brennan PA; Herd MK; Howlett DC; Gibson D; Oeppen RS
Br J Oral Maxillofac Surg; 2012 Jun; 50(4):333-7. PubMed ID: 21371794
[TBL] [Abstract][Full Text] [Related]
43. Differentiation of pleomorphic adenoma and Warthin's tumour of the salivary gland: is long-to-short diameter ratio a useful parameter?
Miao LY; Xue H; Ge HY; Wang JR; Jia JW; Cui LG
Clin Radiol; 2015 Nov; 70(11):1212-9. PubMed ID: 26216455
[TBL] [Abstract][Full Text] [Related]
44. Do magnetic resonance imaging and ultrasound add anything to the preoperative workup of parotid gland tumors?
de Ru JA; van Leeuwen MS; van Benthem PP; Velthuis BK; Sie-Go DM; Hordijk GJ
J Oral Maxillofac Surg; 2007 May; 65(5):945-52. PubMed ID: 17448846
[TBL] [Abstract][Full Text] [Related]
45. Characterization of parotid gland tumors using diffusion-relaxation correlation spectrum imaging: a preliminary study.
Chen W; Geng D; Xu XQ; Hu WT; Dai YM; Wu FY; Zhu LN
Clin Radiol; 2024 Jun; 79(6):e878-e884. PubMed ID: 38582630
[TBL] [Abstract][Full Text] [Related]
46. [Malignant epithelial parotid tumors: CT imaging and histopathologic correlation].
Shen JX; Fan WJ; Lu YC; Xiao P
Ai Zheng; 2007 Jul; 26(7):762-6. PubMed ID: 17626755
[TBL] [Abstract][Full Text] [Related]
47. Pre-treatment MRI predictor of high-grade malignant parotid gland cancer.
Baba A; Kessoku H; Akutsu T; Shimura E; Matsushima S; Kurokawa R; Ota Y; Suzuki T; Kawasumi Y; Yamauchi H; Ikeda K; Ojiri H
Oral Radiol; 2021 Oct; 37(4):611-616. PubMed ID: 33389599
[TBL] [Abstract][Full Text] [Related]
48. Pleomorphic adenoma of parotid gland: delayed enhancement on computed tomography.
Brunese L; Ciccarelli R; Fucili S; Romeo A; Napolitano G; D'Auria V; Collina A; Califano L; Cappabianca S; Sodano A
Dentomaxillofac Radiol; 2008 Dec; 37(8):464-9. PubMed ID: 19033432
[TBL] [Abstract][Full Text] [Related]
49. Non-enhanced MRI in combination with color Doppler flow imaging for improving diagnostic accuracy of parotid gland lesions.
Zhang W; Zuo Z; Luo N; Liu L; Jin G; Liu J; Su D
Eur Arch Otorhinolaryngol; 2018 Apr; 275(4):987-995. PubMed ID: 29430614
[TBL] [Abstract][Full Text] [Related]
50. MRI criteria for the diagnosis of pleomorphic adenoma: a validation study.
Zaghi S; Hendizadeh L; Hung T; Farahvar S; Abemayor E; Sepahdari AR
Am J Otolaryngol; 2014; 35(6):713-8. PubMed ID: 25128908
[TBL] [Abstract][Full Text] [Related]
51. Demographics of benign parotid tumours: Warthin's tumour versus other benign salivary tumours.
Patel DK; Morton RP
Acta Otolaryngol; 2016; 136(1):83-6. PubMed ID: 26449442
[TBL] [Abstract][Full Text] [Related]
52. Multimodality fMRI with perfusion, diffusion-weighted MRI and
Zhu L; Wang J; Shi H; Tao X
J Magn Reson Imaging; 2019 Feb; 49(2):423-432. PubMed ID: 30475438
[TBL] [Abstract][Full Text] [Related]
53. The value of combining conventional, diffusion-weighted and dynamic contrast-enhanced MR imaging for the diagnosis of parotid gland tumours.
Tao X; Yang G; Wang P; Wu Y; Zhu W; Shi H; Gong X; Gao W; Yu Q
Dentomaxillofac Radiol; 2017 Aug; 46(6):20160434. PubMed ID: 28299943
[TBL] [Abstract][Full Text] [Related]
54. Histogram analysis of apparent diffusion coefficient maps for differentiating malignant from benign parotid gland tumors.
Ma G; Zhu LN; Su GY; Hu H; Qian W; Bu SS; Xu XQ; Wu FY
Eur Arch Otorhinolaryngol; 2018 Aug; 275(8):2151-2157. PubMed ID: 29961924
[TBL] [Abstract][Full Text] [Related]
55. [Imaging in parotid tumors: US versus MRT].
Steiner E; Turetschek K; Wunderbaldinger P; Staniszewski K; Franz P; Steurer M; Millesi W
Rofo; 1994 May; 160(5):397-405. PubMed ID: 8173049
[TBL] [Abstract][Full Text] [Related]
56. MRI-based texture analysis for differentiating pediatric craniofacial rhabdomyosarcoma from infantile hemangioma.
Sarioglu FC; Sarioglu O; Guleryuz H; Ozer E; Ince D; Olgun HN
Eur Radiol; 2020 Oct; 30(10):5227-5236. PubMed ID: 32382846
[TBL] [Abstract][Full Text] [Related]
57. Clinicopathological analysis of parotid masses: six-year experience of a tertiary center.
Yazici D; Guney Z; Coktu MY; Yildirim I; Arikan OK
J Pak Med Assoc; 2020 Feb; 70(2):308-312. PubMed ID: 32063626
[TBL] [Abstract][Full Text] [Related]
58. Diffusion-weighted and gadolinium-enhanced dynamic MRI in parotid gland tumors.
Pâris P; Fath L; Schultz P; Veillon F; Riehm S; Severac F; Venkatasamy A
Eur Arch Otorhinolaryngol; 2023 Jan; 280(1):391-398. PubMed ID: 35951107
[TBL] [Abstract][Full Text] [Related]
59. Differentiation of parotid pleomorphic adenoma from Warthin tumor using signal intensity ratios on fat-suppressed T2-weighted magnetic resonance imaging.
Lin W; Ye W; Ma J; Wang S; Chen P; Yang Y; Yin B
Oral Surg Oral Med Oral Pathol Oral Radiol; 2024 Mar; 137(3):310-319. PubMed ID: 38195353
[TBL] [Abstract][Full Text] [Related]
60. Over-expression of glutathione S-transferases, DT-diaphorase and an apparently tumour-specific cytosolic class-3 aldehyde dehydrogenase by Warthin tumours and mucoepidermoid carcinomas of the human parotid gland.
Sreerama L; Sladek NE
Arch Oral Biol; 1996 Jun; 41(6):597-605. PubMed ID: 8937651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
